Expect Less Focus on Psychiatric Effects With Varenicline

Boxed warnings about psychiatric events will be REMOVED from varenicline (Chantix) and bupropion labeling for smoking cessation.

These warnings about mood changes, agitation, nightmares, and other psychiatric risks were originally added based on case reports.

Now a large trial suggests that these meds do NOT increase psychiatric side effects in patients quitting smoking.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals